Pacer Advisors’s Insmed INSM Stock Holding History

Pacer Advisors’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$54K	Sell	502 -6,777	-93%	-$821K	﹤0.01%	2019
2026 Q1	$1.19M	Sell	7,279 -8,304	-53%	-$1.28M	﹤0.01%	1138
2025 Q4	$2.71M	Buy	+15,583	New	+$2.84M	0.01%	935
2024 Q3	–	Sell	-638	Closed	-$42.7K	–	2621
2024 Q2	$42.7K	Sell	638 -898	-58%	-$34.8K	﹤0.01%	3244
2024 Q1	$41.7K	Buy	+1,536	New	+$43K	﹤0.01%	3242
2021 Q2	–	Sell	-1,990	Closed	-$68K	–	1475
2021 Q1	$68K	Sell	1,990 -1,328	-40%	-$50.8K	﹤0.01%	1389
2020 Q4	$110K	Sell	3,318 -548	-14%	-$20K	﹤0.01%	1353
2020 Q3	$124K	Buy	+3,866	New	+$111K	﹤0.01%	1230
2018 Q4	–	Sell	-7,658	Closed	-$155K	–	788
2018 Q3	$155K	Buy	+7,658	New	+$173K	0.01%	1051
2018 Q1	–	Sell	-625	Closed	-$19K	–	1084
2017 Q4	$19K	Buy	+625	New	+$18.5K	﹤0.01%	1098

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Pacer Advisors's INSM Position: Q2 2026 in Review

Pacer Advisors reduced its Insmed (INSM) stake by 93% in Q2 2026, selling an estimated $821K and leaving 502 shares worth $54K. The position accounts for ﹤0.01% of the portfolio, ranked #2019.

Pacer Advisors first reported a position in INSM in Q4 2017 and has held it in 10 quarters since. The position peaked at $2.71M in Q4 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Pacer Advisors held 502 shares of Insmed worth $54K as of Q2 2026.
Pacer Advisors sold 6,777 Insmed shares in Q2 2026, an estimated $821K.
Insmed made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #2019 holding.
Pacer Advisors first reported a position in Insmed in Q4 2017 and has held it in 10 quarters since.
Pacer Advisors's Insmed position peaked at $2.71M in Q4 2025.
666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.